Celldex ends eczema drug development after mid-stage trial failure
FROM THE WIRE · REUTERS.COM
Celldex Therapeutics said on Thursday it would stop developing its experimental drug for eczema after the treatment failed to meet the main and key secondary goals of a mid-stage study.
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralAbandoning a drug in development affects the outlook for the company's pipeline.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Celldex Therapeutics will stop developing its experimental eczema drug.
- 02The treatment failed to meet the main and key secondary goals of a mid-stage study.
- 03The decision was announced on Thursday.